| scholarly article | Q13442814 |
| P2093 | author name string | J L Wrana | |
| M Buchwald | |||
| S J Tang | |||
| M Macías-Silva | |||
| P A Hoodless | |||
| P2860 | cites work | Activation of signalling by the activin receptor complex | Q24308084 |
| MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling | Q24310282 | ||
| TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4 | Q24314661 | ||
| MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma | Q24315119 | ||
| MADR1, a MAD-related protein that functions in BMP2 signaling pathways | Q24317247 | ||
| Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors | Q24319747 | ||
| Molecular mechanisms of Spemann's organizer formation: conserved growth factor synergy between Xenopus and mouse | Q46227290 | ||
| A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway | Q46482720 | ||
| Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily | Q48064097 | ||
| MAD-related proteins in TGF-beta signalling. | Q52198314 | ||
| Differential expression of inhibin subunits and follistatin, but not of activin receptor type II, during early murine embryonic development. | Q52229140 | ||
| Induction of epidermis and inhibition of neural fate by Bmp-4 | Q52508863 | ||
| Mad about SMADs | Q58983799 | ||
| TGF beta signals through a heteromeric protein kinase receptor complex | Q24337608 | ||
| Cloning and characterization of a human type II receptor for bone morphogenetic proteins | Q24561622 | ||
| Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin | Q24612297 | ||
| Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs | Q24651958 | ||
| TGF-beta signalling from cell membrane to nucleus through SMAD proteins | Q28131770 | ||
| The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling | Q28243202 | ||
| Mechanism of activation of the TGF-beta receptor | Q28245861 | ||
| Smad4 and FAST-1 in the assembly of activin-responsive factor | Q28248490 | ||
| Characterization of type I receptors for transforming growth factor-beta and activin | Q28251169 | ||
| Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5 | Q28284508 | ||
| Ventral mesodermal patterning in Xenopus embryos: expression patterns and activities of BMP-2 and BMP-4 | Q28288976 | ||
| Signal transduction by members of the transforming growth factor-beta superfamily | Q28303118 | ||
| Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor | Q28507865 | ||
| Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2 | Q28511063 | ||
| Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors | Q28512760 | ||
| Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor | Q28580056 | ||
| Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase | Q28584256 | ||
| The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase | Q28628494 | ||
| Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling | Q28631440 | ||
| Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components | Q29036482 | ||
| A transcriptional partner for MAD proteins in TGF-beta signalling | Q29622823 | ||
| XSmad2 directly activates the activin-inducible, dorsal mesoderm gene XFKH1 in Xenopus embryos. | Q32172187 | ||
| A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity | Q33886942 | ||
| Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects | Q36235769 | ||
| Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex | Q36645287 | ||
| Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. | Q36665327 | ||
| Colocalization of BMP 7 and BMP 2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development | Q36686718 | ||
| TGF-beta signalling through the Smad pathway | Q36914476 | ||
| Mammalian dwarfins are phosphorylated in response to transforming growth factor beta and are implicated in control of cell growth | Q37378595 | ||
| Identification of Smad2, a human Mad-related protein in the transforming growth factor beta signaling pathway | Q38349140 | ||
| TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling | Q41083690 | ||
| Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts | Q41090627 | ||
| Msx2 is a transcriptional regulator in the BMP4-mediated programmed cell death pathway | Q41104494 | ||
| Inhibitory control of neural differentiation in mammalian cells | Q41111139 | ||
| Drosophila Dpp signaling is mediated by the punt gene product: A dual ligand-binding type II receptor of the TGFβ receptor family | Q41358724 | ||
| In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria | Q41387920 | ||
| Studies with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo | Q41436510 | ||
| Activin/EDF as an inhibitor of neural differentiation. | Q41714120 | ||
| Disruption of BMP signals in embryonic Xenopus ectoderm leads to direct neural induction | Q44507413 | ||
| P433 | issue | 40 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 25628-36 | |
| P577 | publication date | 1998-10-02 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2 | |
| P478 | volume | 273 |
| Q28203670 | A Role for BMP Heterodimers in Roof Plate-Mediated Repulsion of Commissural Axons |
| Q22003817 | A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation |
| Q28141283 | A Smad transcriptional corepressor |
| Q34990909 | A clinical and experimental overview of sirenomelia: insight into the mechanisms of congenital limb malformations. |
| Q21284180 | A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs). |
| Q36288327 | A pair of transmembrane receptors essential for the retention and pigmentation of hair |
| Q33229597 | A road map toward defining the role of Smad signaling in hematopoietic stem cells |
| Q27643809 | A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor |
| Q34211818 | ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant |
| Q54248766 | ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. |
| Q35127963 | ALK1 as an emerging target for antiangiogenic therapy of cancer |
| Q30811602 | ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression |
| Q28144663 | Activation of Smad1-mediated transcription by p300/CBP |
| Q38298464 | Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation |
| Q96220920 | Activin A forms a non-signaling complex with ACVR1 and type II Activin/BMP receptors via its finger 2 tip loop |
| Q46852208 | Activin acutely sensitizes dorsal root ganglion neurons and induces hyperalgesia via PKC-mediated potentiation of transient receptor potential vanilloid I. |
| Q24321895 | Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis |
| Q24677057 | Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis |
| Q46377767 | Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation |
| Q22254570 | Activin receptor-like kinase 2 can mediate atrioventricular cushion transformation |
| Q40819395 | Activin receptors are expressed on human lung fibroblast and activin A facilitates fibroblast-mediated collagen gel contraction |
| Q34038590 | Activin signal transduction pathways |
| Q33753080 | AcvR1-mediated BMP signaling in second heart field is required for arterial pole development: implications for myocardial differentiation and regional identity. |
| Q27682737 | An Activin A/BMP2 Chimera, AB204, Displays Bone-Healing Properties Superior to Those of BMP2 |
| Q34006810 | An Activin A/BMP2 chimera, AB215, blocks estrogen signaling via induction of ID proteins in breast cancer cells |
| Q34307660 | An emerging role for co-receptors in inhibin signal transduction |
| Q37089050 | An investigation of BMP-7 mediated alterations to BMP signalling components in human tenocyte-like cells |
| Q39965669 | Analysis of the contribution of receptor subdomains to the cooperative binding and internalization of transforming growth factor-beta (TGF-beta) type I and type II receptors |
| Q48302210 | Animal models of fibrodysplasia ossificans progressiva. |
| Q42506970 | Antitumor activity of ALK1 in pancreatic carcinoma cells |
| Q24647244 | Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways |
| Q28507415 | Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart |
| Q38294847 | Autoregulation of Xvent-2B; direct interaction and functional cooperation of Xvent-2 and Smad1. |
| Q28586282 | BMP receptor IA is required in the mammalian embryo for endodermal morphogenesis and ectodermal patterning |
| Q36639706 | BMP signaling and spadetail regulate exit of muscle precursors from the zebrafish tailbud |
| Q36659526 | BMP signaling in the cartilage growth plate. |
| Q37849623 | BMP signaling in the nephron progenitor niche |
| Q37776859 | BMP signaling in vascular development and disease |
| Q35024134 | BMP signaling is required for cell cleavage in preimplantation-mouse embryos |
| Q28507228 | BMP signaling through ACVRI is required for left-right patterning in the early mouse embryo |
| Q24611307 | BMP type I receptor inhibition reduces heterotopic [corrected] ossification |
| Q24631766 | BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II |
| Q24328930 | BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells |
| Q40221971 | BMP-dependent activation of caspase-9 and caspase-8 mediates apoptosis in pulmonary artery smooth muscle cells |
| Q40498143 | BMP4 inhibits proliferation and promotes myocyte differentiation of lung fibroblasts via Smad1 and JNK pathways |
| Q52142757 | BMP7 controls collecting tubule cell proliferation and apoptosis via Smad1-dependent and -independent pathways. |
| Q28585269 | BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling |
| Q42951218 | BMP7 signaling via BMPR1A, BMPR1B inhibits the proliferation of lung large carcinoma NCI-H460 cell |
| Q42445316 | BMPs and BMPRs in chicken ovary and effects of BMP-4 and -7 on granulosa cell proliferation and progesterone production in vitro |
| Q43144441 | Bmp inhibition is necessary for post-gastrulation patterning and morphogenesis of the zebrafish tailbud |
| Q24555732 | Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo |
| Q37947050 | Bone Morphogenetic Protein functions as a context-dependent angiogenic cue in vertebrates |
| Q36466135 | Bone Morphogenetic Protein-2 (BMP-2) Activates NFATc1 Transcription Factor via an Autoregulatory Loop Involving Smad/Akt/Ca2+ Signaling |
| Q33968772 | Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF). |
| Q38354930 | Bone morphogenetic protein heterodimers assemble heteromeric type I receptor complexes to pattern the dorsoventral axis |
| Q36325743 | Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation |
| Q34068835 | Bone morphogenetic protein signaling and growth suppression in colon cancer |
| Q24316099 | Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression |
| Q44301578 | Bone morphogenetic protein signaling in articular chondrocyte differentiation |
| Q26822802 | Bone morphogenetic protein signaling in nephron progenitor cells |
| Q42025588 | Bone morphogenetic protein signaling modulates myocardin transactivation of cardiac genes |
| Q44533976 | Bone morphogenetic protein signalling in NGF-stimulated PC12 cells |
| Q28141605 | Bone morphogenetic protein-3 is a negative regulator of bone density |
| Q40007492 | Bone morphogenetic protein-4 interacts with activin and GnRH to modulate gonadotrophin secretion in LbetaT2 gonadotrophs |
| Q73821820 | Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro |
| Q36933692 | Bone morphogenic protein signaling is a major determinant of dentate development |
| Q33804968 | CD44 and hyaluronan promote the bone morphogenetic protein 7 signaling response in murine chondrocytes |
| Q36321864 | CD44 modulates Smad1 activation in the BMP-7 signaling pathway |
| Q27347461 | Caenorhabditis elegans SMA-10/LRIG is a conserved transmembrane protein that enhances bone morphogenetic protein signaling |
| Q41912514 | Casein kinase II contributes to the synergistic effects of BMP7 and BDNF on Smad 1/5/8 phosphorylation in septal neurons under hypoglycemic stress |
| Q34681356 | Characterization of a bone morphogenetic protein-responsive Smad-binding element |
| Q30976369 | Characterization of the mouse Smad1 gene and its expression pattern in adult mouse tissues |
| Q47919138 | Characterization of zebrafish smad1, smad2 and smad5: the amino-terminus of smad1 and smad5 is required for specific function in the embryo. |
| Q40278602 | Concerted action of Smad and CREB-binding protein regulates bone morphogenetic protein-2-stimulated osteoblastic colony-stimulating factor-1 expression |
| Q38332721 | Conditional BMP inhibition in Xenopus reveals stage-specific roles for BMPs in neural and neural crest induction |
| Q35025212 | Consequences of knocking out BMP signaling in the mouse |
| Q36978228 | Constitutively active ALK2 receptor mutants require type II receptor cooperation |
| Q38659223 | Control of Adult Neurogenesis by Short-Range Morphogenic-Signaling Molecules |
| Q35563823 | Control of endocardial cushion and cardiac valve maturation by BMP signaling pathways |
| Q37641781 | Control of the bone morphogenetic protein 7 gene in developmental and adult life |
| Q39791091 | Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads |
| Q40775132 | Correlation between ALK-6 (BMPR-IB) distribution and responsiveness to osteogenic protein-1 (BMP-7) in embryonic mouse bone rudiments |
| Q24292510 | Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells |
| Q28213027 | Crossing Smads |
| Q30479504 | Cx43 mediates TGF-beta signaling through competitive Smads binding to microtubules |
| Q42395321 | Dedifferentiation of human articular chondrocytes is associated with alterations in expression patterns of GDF-5 and its receptors |
| Q28142906 | Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells |
| Q35896949 | Differential requirement of bone morphogenetic protein receptors Ia (ALK3) and Ib (ALK6) in early embryonic patterning and neural crest development |
| Q50525535 | Direct visualization of Smad1/5/8-mediated transcriptional activity identifies podocytes and collecting ducts as major targets of BMP signalling in healthy and diseased kidneys. |
| Q35498717 | Distinct bone morphogenetic proteins activate indistinguishable transcriptional responses in nephron epithelia including Notch target genes. |
| Q90295152 | Distinctive role of ACVR1 in dentin formation: requirement for dentin thickness in molars and prevention of osteodentin formation in incisors of mice |
| Q24337521 | Dominant-negative ALK2 allele associates with congenital heart defects |
| Q39747803 | Effects of cartilage-derived morphogenetic protein-3 on the expression of chondrogenic and osteoblastic markers in the pluripotent mesenchymal C3H10T1/2 cell line |
| Q37714515 | Effects of exogenous recombinant human bone morphogenic protein-7 on the corneal epithelial mesenchymal transition and fibrosis |
| Q22008597 | Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily |
| Q33964233 | Estrogen opposes the apoptotic effects of bone morphogenetic protein 7 on tissue remodeling |
| Q24313392 | Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways |
| Q34812947 | Factors that modulate the effects of bone morphogenetic protein-induced periodontal regeneration: a critical review |
| Q43832538 | Fate alteration of neuroepithelial cells from neurogenesis to astrocytogenesis by bone morphogenetic proteins |
| Q24322184 | Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6 |
| Q90261184 | Fostering open collaboration in drug development for paediatric brain tumours |
| Q37397463 | Functional analysis of saxophone, the Drosophila gene encoding the BMP type I receptor ortholog of human ALK1/ACVRL1 and ACVR1/ALK2. |
| Q31879070 | Functional characterization and genetic mapping of alk8. |
| Q47812633 | Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling |
| Q39640769 | Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension |
| Q49843883 | Genetic polymorphisms in bone morphogenetic protein receptor type IA gene predisposes individuals to ossification of the posterior longitudinal ligament of the cervical spine via the smad signaling pathway |
| Q30432180 | Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development. |
| Q38942069 | Gremlin1 preferentially binds to bone morphogenetic protein-2 (BMP-2) and BMP-4 over BMP-7. |
| Q24795748 | Growth factor signaling in lung morphogenetic centers: automaticity, stereotypy and symmetry |
| Q34116893 | Growth factors and their receptors in pancreatic cancer |
| Q40685877 | Growth/differentiation factor-5 induces growth arrest and apoptosis in mouse B lineage cells with modulation by Smad. |
| Q51454017 | HNF-4alpha Negatively Regulates Hepcidin Expression Through BMPR1A in HepG2 Cells. |
| Q33691285 | Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms |
| Q35443250 | Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations |
| Q24324369 | Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1 |
| Q43640421 | Human transforming growth factor-beta activates a receptor serine/threonine kinase from the intravascular parasite Schistosoma mansoni |
| Q40035670 | Hyaluronan promotes the chondrocyte response to BMP-7. |
| Q41903017 | Hyperactive BMP signaling induced by ALK2(R206H) requires type II receptor function in a Drosophila model for classic fibrodysplasia ossificans progressiva |
| Q38459223 | Identification of key genes associated with the effect of estrogen on ovarian cancer using microarray analysis |
| Q24310450 | Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses |
| Q37038713 | Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation. |
| Q40682191 | Inhibin is an antagonist of bone morphogenetic protein signaling |
| Q41582074 | Inhibition of osteoclast generation: a novel function of the bone morphogenetic protein 7/osteogenic protein 1 |
| Q34790572 | Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP) |
| Q35774487 | Insulin-Like Growth Factor I Suppresses Bone Morphogenetic Protein Signaling in Prostate Cancer Cells by Activating mTOR Signaling |
| Q33833357 | Intracellular signaling of the TGF-beta superfamily by Smad proteins |
| Q38722724 | Irx3 and Bmp2 regulate mouse mesenchymal cell chondrogenic differentiation in both a Sox9-dependent and -independent manner |
| Q35435068 | Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1. |
| Q24808927 | MAB21L2, a vertebrate member of the Male-abnormal 21 family, modulates BMP signaling and interacts with SMAD1 |
| Q34642292 | Male germ cell specification and differentiation |
| Q35955914 | Matrilysin (MMP-7) inhibition of BMP-7 induced renal tubular branching morphogenesis suggests a role in the pathogenesis of human renal dysplasia. |
| Q54979603 | Microarray Analysis of the Molecular Mechanism Involved in Parkinson's Disease. |
| Q28213987 | Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells |
| Q35902283 | Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction |
| Q33739345 | Morphogen gradients: new insights from DPP. |
| Q24296422 | Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis |
| Q35567595 | Neuropeptide Y, substance P, and human bone morphogenetic protein 2 stimulate human osteoblast osteogenic activity by enhancing gap junction intercellular communication. |
| Q37864607 | New insights on the roles of BMP signaling in bone-A review of recent mouse genetic studies |
| Q35163981 | New intracellular components of bone morphogenetic protein/Smad signaling cascades |
| Q43508070 | Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads |
| Q30352491 | Normal gonadotropin production and fertility in gonadotrope-specific Bmpr1a knockout mice. |
| Q40331060 | Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling |
| Q22011195 | OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways |
| Q27023170 | Oligomeric interactions of TGF-β and BMP receptors |
| Q28069613 | Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors |
| Q40694532 | Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. |
| Q28569056 | Ovarian follicle populations of the rat express TGF-beta signalling pathways |
| Q64967797 | Perspectives of small molecule inhibitors of activin receptor‑like kinase in anti‑tumor treatment and stem cell differentiation (Review). |
| Q36949252 | Podocyte-derived BMP7 is critical for nephron development |
| Q34594261 | Potential roles for endometrial inhibins, activins and follistatin during human embryo implantation and early pregnancy |
| Q43746980 | Proteasomal degradation of Smad1 induced by bone morphogenetic proteins |
| Q54210039 | Protein kinase A is a negative regulator of renal branching morphogenesis and modulates inhibitory and stimulatory bone morphogenetic proteins. |
| Q34599321 | Regulation and Role of TGFβ Signaling Pathway in Aging and Osteoarthritis Joints |
| Q43073793 | Regulation of ADMP and BMP2/4/7 at opposite embryonic poles generates a self-regulating morphogenetic field |
| Q24312839 | Regulation of ALK-1 signaling by the nuclear receptor LXRbeta |
| Q28510682 | Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor |
| Q38286149 | Research on growth factors in periodontology |
| Q38614636 | Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. |
| Q40694927 | SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1. |
| Q22008583 | SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor |
| Q24299813 | SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 |
| Q34454386 | SMAD signaling regulates CXCL12 expression in the bone marrow niche, affecting homing and mobilization of hematopoietic progenitors |
| Q51696811 | Screening for Inhibitors of Kinase Autophosphorylation. |
| Q38255698 | Side effects of cytokines approved for therapy |
| Q33697455 | Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins |
| Q34599300 | Smad signalling in the ovary |
| Q24291053 | Sorting nexin 6, a novel SNX, interacts with the transforming growth factor-beta family of receptor serine-threonine kinases |
| Q91812737 | Specification of BMP Signaling |
| Q38934096 | Structural Basis of Intracellular TGF-β Signaling: Receptors and Smads |
| Q34307644 | Studying TGF-beta superfamily signaling by knockouts and knockins |
| Q34316282 | Suv39h histone methyltransferases interact with Smads and cooperate in BMP-induced repression |
| Q52178412 | TAKs, thylakoid membrane protein kinases associated with energy transduction. |
| Q40618112 | TBX5 overexpression stimulates differentiation of chamber myocardium in P19C16 embryonic carcinoma cells. |
| Q22253317 | TGF-beta signaling by Smad proteins |
| Q28139850 | TGF-beta signaling by Smad proteins |
| Q34316170 | TGF-beta signaling in mammary gland development and tumorigenesis. |
| Q35130945 | TGF-betas: their role in testicular function and Sertoli cell tight junction dynamics. |
| Q28142605 | TGFbeta signaling in growth control, cancer, and heritable disorders |
| Q34713446 | TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility |
| Q36083442 | Tgf-beta superfamily and mouse craniofacial development: interplay of morphogenetic proteins and receptor signaling controls normal formation of the face. |
| Q28239297 | Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway |
| Q36242266 | The BMP signaling and in vivo bone formation |
| Q27640861 | The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly |
| Q92923287 | The Role of Bone Morphogenetic Protein 7 (BMP-7) in Inflammation in Heart Diseases |
| Q33800658 | The Smads. |
| Q91935963 | The TGFβ type I receptor TGFβRI functions as an inhibitor of BMP signaling in cartilage |
| Q26752839 | The biological function of type I receptors of bone morphogenetic protein in bone |
| Q36677622 | The mechanism of phosphorus as a cardiovascular risk factor in CKD |
| Q28508419 | The novel type I serine-threonine kinase receptor Alk8 binds TGF-beta in the presence of TGF-betaRII |
| Q38669186 | The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva. |
| Q38809268 | The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signaling |
| Q62060038 | Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease |
| Q33717452 | Transcriptional control of human antigen R by bone morphogenetic protein |
| Q53663107 | Transcriptional regulation of Xbr-1a/Xvent-2 homeobox gene: analysis of its promoter region. |
| Q44189946 | Transforming growth factor beta (TGFbeta ) signaling via differential activation of activin receptor-like kinases 2 and 5 during cardiac development. Role in regulating parasympathetic responsiveness |
| Q34307632 | Transforming growth factor beta signalling in vitro and in vivo: activin ligand-receptor interaction, Smad5 in vasculogenesis, and repression of target genes by the deltaEF1/ZEB-related SIP1 in the vertebrate embryo. |
| Q39939459 | Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth |
| Q39344496 | Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes |
| Q35172753 | Transforming growth factor-beta and its role in asthma |
| Q34438032 | Transforming growth factor-beta signal transduction in epithelial cells. |
| Q35177514 | Transforming growth factor-beta stimulates epithelial-mesenchymal transformation in the proepicardium |
| Q40418298 | Transforming growth factor-beta-activated kinase-1 (TAK1), a MAP3K, interacts with Smad proteins and interferes with osteogenesis in murine mesenchymal progenitors |
| Q73920220 | Transient expression of activin betaA mRNA on osteoprogenitor cells in rat bone regeneration after drill-hole injury |
| Q39285598 | Trichocyalides A and B, new inhibitors of alkaline phosphatase activity in bone morphogenetic protein-stimulated myoblasts, produced by Trichoderma sp. FKI-5513. |
| Q35026971 | Two major Smad pathways in TGF-beta superfamily signalling. |
| Q74145184 | Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration |
| Q35054155 | Update on the molecular genetics of vascular anomalies |
| Q90733480 | VWC2 Increases Bone Formation Through Inhibiting Activin Signaling |
| Q24298969 | Wilms' tumorigenesis is altered by misexpression of the transcriptional co-activator, CITED1 |
| Q53502451 | Wtap is required for differentiation of endoderm and mesoderm in the mouse embryo. |
| Q55022278 | miR-208a-3p Suppresses Osteoblast Differentiation and Inhibits Bone Formation by Targeting ACVR1. |
| Q40600202 | p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1. |
| Q37431818 | p63 Suppresses non-epidermal lineage markers in a bone morphogenetic protein-dependent manner via repression of Smad7. |
Search more.